Comparison of the genetic abnormalities revealed by sequencing somatic tumor DNA (Tempus Oncology) from Patients 1 and 2 indicated that, while both tumors had mutations in KRAS and TP53, Patient 2's tumor had a focal DNA copy number gain encompassing c-MYC on chromosome 8. This evidence concerns the gene MYC and neoplasm.